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anatomical and temporal expression during
rat Achilles tendon healing
Eva Runesson1*, Paul Ackermann2, Jón Karlsson1 and Bengt I Eriksson1Abstract
Background: The recent discovery of residing tendon stem/progenitor cells has triggered a growing interest in
stem cells as a useful tool in tendon repair. Our knowledge of their involvement in naturally healing tendons is,
however, sparse. The aim of this study was to identify and determine stem/progenitor cells in relation to different
healing phases and regions in a rat model of Achilles tendon rupture.
Methods: Surgery was performed to create a mid-tendon rupture on the right Achilles tendon of 24 rats, whereas
the left tendon was used as a control. Tendons were harvested at one, two, eight and 17 weeks post-rupture and
stained with antibodies specific to stem/progenitor cells (Octamer-binding transcription factor 3/4 (Oct 3/4) and
nucleostemin), migrating cells (Dynamin 2 (Dyn 2)) and leukocytes (CD45). A histological examination was
performed on sections stained with Alcian blue.
Results: At one and two weeks post-rupture, a large number of stem/progenitor cells were discovered throughout
the tendon. Most of these cells were nucleostemin positive, whereas only a few Oct 3/4-positive cells were found,
mainly situated inside the injury region (I region). At eight and 17 weeks, the increment in stem/progenitor cells
had diminished to equal that in the control tendons. At all time points, Oct 3/4-positive cells were also found in the
connective tissue surrounding the tendon and at the muscle-tendon junction in both ruptured and control tendons
and were often seen at the same location as the migration marker, Dyn 2.
Conclusions: The whole length of the Achilles tendon is infiltrated by stem/progenitor cells at early time points after
a mid-tendon rupture. However, different stem/progenitor cell populations exhibit varying anatomical and temporal
expressions during Achilles tendon healing, suggesting distinct reparative implications. Oct 3/4 may thus act as a more
local, migrating stem/progenitor cell involved in injury-site-specific regenerative effects, as compared to the more
general proliferative role of nucleostemin-positive stem/progenitor cells.Background
Clinically, there is as yet no treatment/method to speed
up or improve tendon repair in order finally to re-
create a fully functional tendon. The tendon healing
process is commonly described in three phases. The
inflammatory phase (approximately 1–2 weeks), a short
period of massive influx of erythrocytes and inflammatory* Correspondence: eva.runesson@gu.se
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2–6 weeks), in which the proliferation and migration of
both intrinsic and extrinsic cells appear to occur [1, 2].
The reparative phase is followed by a remodelling phase
(approximately 4- weeks) in order to stabilise, align and
mature the tendon structure [3]. Unfortunately, despite
its ability to heal, a ruptured tendon never attains the
same biochemical properties or mechanical strength as
an intact tendon [4–6]. The discovery of tendon-specific
stem/progenitor cells [7] has stimulated research on the
opportunity to utilise these stem/progenitor cells to pro-
mote tendon healing.ticle is distributed under the terms of the Creative Commons Attribution 4.0
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cells influence tendon healing processes is still partially
unknown and it is therefore important to obtain a better
understanding of the regulatory mechanisms in tendon
repair. Tendon stem/progenitor cells have been found to
exist in several different regions in and around the tendon
tissue, possibly with various influences on the healing
tendon tissue [8–11]. Recent studies have demonstrated a
residing stem cell pool in the distal region of rat Achilles
and patellar tendons, in a higher proportion than in the
mid-tendon region [10, 11]. Moreover, the peritendon
region appears to harbour stem/progenitor cells, possibly
involved in both tendon homeostasis and tendon repair
processes [8, 9]. It has further been found that stem/pro-
genitor cells originating from regions within and around
tendon tissue have both similar and dissimilar properties,
indicating a dual mechanism for tendon healing (intrinsic
and/or extrinsic) [8, 9]. The stem/progenitor cells from
the peritendon, as well as the tendon proper, could be
driven towards osteogenic differentiation, possibly leading
to undesirable ectopic tissue during tendon healing [8, 9].
Furthermore, it has been found that the progenitor cells
originating from the tendon proper have greater poten-
tial for forming tendon-like tissue compared with the
progenitor cells originating from the tissue surrounding
the tendon [12]. Most studies of progenitor cells in-
volved in tendon healing have used in-vitro methods
[12–14] or have mainly been performed on regions in
or around the injury [11]. The identification of regional
and temporal differences in stem/progenitor cells in the
natural in-vivo tendon healing processes may provide
crucial information when it comes to selecting the best
strategies for the internal activation of tendon regener-
ation and healing.
In the present study, we used a rat Achilles tendon
rupture model to study histological tendon morphology,
stem/progenitor cells and migration during early and
late tendon repair in different regions of the whole
length of the Achilles tendon. It was hypothesised that,
after a mid-Achilles tendon injury, different stem/pro-
genitor cells would exhibit differential regional distribu-
tion and time-dependent expression during healing.Methods
Animals
Twenty-four female Sprague–Dawley rats (Charles River,
Germany) with an initial weight of 195–221 g (median =
205 g) were included in the study. The animals were accli-
matised and housed three per cage in a 12-hour dark/light
cycle for one week prior to any surgical procedure. The
animals were housed with free access to food and water
and all the experiments were approved by the Gothenburg
Ethical Committee on Animal Research (Dnr: 257–2009).Surgery model
Prior to the surgical procedure, the rats were anaesthe-
tised with an isoflurane inhalation (Baxter Medical AB,
Sweden) in a cage, transferred to an aseptic clean bench
and connected to a breathing mask with a constant flow
of isoflurane. Analgesic treatment was performed once
pre- and post-operatively with a subcutaneous injection
of Temgesic (0.3 mg/ml, Schering-Plough, Sweden). A
1 cm longitudinal incision was made lateral to the right
Achilles tendon. The Achilles tendon complex was ex-
posed and the plantaris tendon was gently moved aside.
A plain forceps was slid under the Achilles tendon and a
complete rupture was performed by tearing the collagen
fibres apart using a Ewald teeth forceps (TG instrument,
Helsingborg, Sweden). The rupture was made approxi-
mately 0.5 cm from the calcaneal insertion, carefully
leaving the plantaris tendon undamaged. The skin was
sutured and the rats were allowed unrestricted move-
ment in their cages. In all animals, the Achilles tendon
from the contralateral left limb was left intact and served
as a control. During the first week post-surgery, rats
were monitored daily for signs of pain, stress or infection.
There were no animal drop-outs during the experiment
and the rats were euthanised with a lethal intraperitoneal
dose of sodium pentobarbital (Apoteket Production &
Laboratorier AB (APL), Sweden) in groups of six at time
points one, two, eight and 17 weeks post-surgery.
Histology and immunohistochemistry
At harvest, the Achilles tendon complex, including both
the calcaneal bone and parts of the gastrocnemius
muscle, from both the right (ruptured) and left (control)
tendons, was put in Histofix solution (Histolab Products
AB, Göteborg, Sweden) for 24 h at 4 °C, followed by
decalcification in 0.5 M EDTA/0.5 % paraformaldehyde
solution for a period of two weeks, washed, dehydrated
and embedded in paraffin. Serial longitudinal sections in
the coronal plane (5–6 μm) were cut on a microtome
and mounted on plus-slide glasses (Histolab Products
AB, Göteborg, Sweden). After deparaffinisation, sections
were stained with Alcian blue/Van Gieson/HTX to obtain
a histological overview of the tendon samples.
Immunofluorescence was performed on tendon sec-
tions using the stem/progenitor cell markers, nucleoste-
min (1/100, polyclonal GT 15050, Neuromics, Edina,
USA) and Oct 3/4 (1/50, monoclonal sc-5279, Santa
Cruz Biotech, Santa Cruz, CA), the migration/endo-
cytosis marker, Dynamin 2 (1/100, polyclonal ab 3457,
Abcam, Cambridge, UK), and the common leukocyte
antigen, CD45 (1/100, monoclonal MCA43GA, AbD
Serotec, Oxford, UK).
Sample sections were deparaffinised, followed by a heat-
induced antigen retrieval step in HIER-EDTA pH 9.0
(used for nucleostemin and Oct 3/4, Nordic Biosite, Täby,
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CD 45, Nordic Biosite, Täby, Sweden). Sections were
permeabilised in 0.1 % Triton X-100, washed, blocked
with Image-iT® FX Signal Enhancer (Life Technologies,
Carlsbad, CA) for 20 min and incubated with primary
antibodies over night at 4 °C. On the following day, the
sections were washed and incubated with Alexa-Fluor
conjugated secondary antibodies (goat anti-rabbit 488
used for Dynamin 2, donkey anti-goat 594 used for
nucleostemin, goat anti-mouse 546 used for Oct 3/4 and
goat anti-mouse 594 for CD45) for three hours at RT. The
samples were covered with ProLong® Gold Antifade
Reagent with DAPI (Life Technologies, Carlsbad, CA).
Positive control tissue came from human seminoma (for
stem cell markers nucleostemin and Oct 3/4), rat spleen
(for CD 45) and rat thymus (for Dynamin 2). Negative
controls were derived from the original samples with the
exclusion of the primary antibody. Sections were exam-
ined using a Nikon fluorescence microscope (Eclipse
E600, Nikon, Tokyo, Japan).
Histological analysis
Three regional areas (distal region (D), injury region (I)
and midproximal region (MP)) were defined, from both
the right ruptured tendon and the left contralateral ten-
don, and stained with Alcian blue/Van Gieson. The dis-
tal region was set at a length of ~2 mm (excluding the
calcified fibrocartilage zone), the injury region at a
length of ~4 mm and the midproximal region as all the
parts of the tendon above the injury region to the
muscle-tendon insertion (Fig. 1). Visual histological eval-
uations of Alcian blue/Van Gieson and fluorescence
staining were performed in the different regions at all
time points. The cell density (cells/mm2), nucleosteminFig. 1 Definition of tendon regions. Sections of whole rat Achilles tendon
tendon were used to define the distal (D), injury (I) and midproximal (MP)density (nucleostemin-positive cells/mm2) and percentage
of cells positive for nucleostemin were further calculated
in all parts of the tendon at all time points. Furthermore,
calculations of nucleostemin-positive cells in injured ten-
dons at 17 weeks post-rupture were performed in five
different regions, distal region (D), injury region (I) (with
no visible Alcian blue staining), midproximal region (MP)
(with no visible Alcian blue staining), surrounding con-
nective tissue region (CT) and regions inside the tendon
proper containing strong Alcian blue staining (AB) (Alcian
blue islands).Image calculation
To calculate the cell density, nucleostemin-stained cell
density and percentage of nucleostemin-positive cells, im-
ages were captured along the whole tendon, excluding
only the parts with visible damage and low-integrity struc-
tures due to sample preparation. One slide from each
sample was used for image analysis and all exposures were
performed at the same settings. All images for calculation
purposes were captured under a 20X objective, giving an
image view of 0.6 mm x 0.46 mm (for all views). From
each time point, six ruptured and six control (contralateral
tendon) tendons were calculated. In each view, an auto-
matic calculation was made with the NIS-element soft-
ware (NIKON, Tokyo, Japan). First, threshold levels were
defined for blue (DAPI) and red fluorescence (nucleoste-
min) and they were used in all calculations. Automatic
calculations were then made on DAPI/nucleostemin
merged pictures using “counting object” as the calculation
setting. The total number of DAPI-stained cells/mm2 and
the number of nucleostemin-positive cells/DAPI-stained
cells were recorded and presented as the total number ofin the coronal plane from control (a) and ruptured (b) rat Achilles
regions. Staining = Alcian blue/Van Gieson
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centage of nucleostemin-positive cells.
To calculate the percentage of nucleostemin-positive
cells in injured tendons at 17 weeks post-rupture, three
representative areas of approximately 0.6 mm x 0.46 mm
were selected from the five different regions. Counting
was performed manually on DAPI/nucleostemin merged
images and calculated as the percentage of nucleostemin-
positive cells.
Statistics
Data are presented with the median and interquartile range
(IQR). The Kruskal-Wallis test (more than two independent
groups) was used when studying possible time-dependent
differences in total cells/mm2, nucleostemin-stained cells/
mm2 and the percentage of nucleostemin-positive cells,
followed by the Mann–Whitney U-test (post-hoc, two inde-
pendent groups). The Mann–Whitney U-test was used to
test for differences between control and ruptured tendon at
different time points. The same statistical method was per-
formed when the percentages of nucleostemin-positive cells
in different regions of injured rat Achilles tendon 17 weeks
post-rupture were compared. All analyses were performed
using SPSS software (IBM, SPSS version 19.0) and statistical
significance was set at p < 0.05.
Results
Tissue morphology
Areas of proteoglycan-producing cells, as detected by
Alcian blue, in all control tendons were only found in
the distal (D) region and there were no visible changesFig. 2 Histology of healing tendon at week 17 post-rupture. A residing isla
I regions of late healing tendon (a). An enlargement of the dashed white b
where further magnification shows rounded chondrocyte-like cells (white aover time. The ruptured tendons displayed a different
location for the Alcian blue staining as compared to the
controls. At weeks one and two post-rupture, weak
Alcian blue staining was observed, equally distributed in-
side the whole length of the Achilles tendon. At week 17
post-rupture, distinct islands of Alcian blue staining were
seen in the injury (I) and mid/proximal (MP) regions of
the ruptured tendon (Fig. 2). Cells in and around these
Alcian blue islands had rounded shapes more similar to
chondrocytes (Fig. 2). As a result, during the observation
period 17 weeks post-rupture, the morphology did not
return to normal.Immunohistological analyses of Oct 3/4-, Dynamin 2- and
CD 45-positive cells
Few CD 45-positive cells in both control and ruptured
tendons could be observed in the close vicinity of blood
vessels located in the connective tissue surrounding the
tendon. No CD 45-positive cells were seen inside any of
the regions of the control tendons. In the ruptured ten-
dons, however, at one and two weeks post-rupture, some
CD 45-positive cells were found in the I region (Fig. 3).
Dynamin 2-positive cells were found in control and rup-
tured tendons both in the connective tissue surrounding
the tendon (Fig. 4) and at the muscle-tendon junction
(Fig. 4). At the early time points post-rupture (1 and
2 weeks), some Dynamin 2-positive cells were observed
deeper inside the I region, whereas no Dynamin 2-positive
cells were seen inside the tendon proper of the control
tendons (Fig. 5).nd of Alcian blue-positive proteoglycan matrix was seen in the MP and
ox in (a) shows an Alcian blue-positive area in the MP region (b),
rrows) in this area (c)
Fig. 3 Leukocytes in early tendon healing. Photomicrographs show the histological staining (a) and adjacent consecutive sections of CD 45 (red)
(common leukocyte antigen) staining in rat tendon (b) from one week post-rupture. Positive antibody control tissue was rat spleen (c,d). Cell
nuclei stained with DAPI (blue). Images are merged with green auto-fluorescence to make the red blood cells (green) visible
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control and ruptured tendons in the loose connective
tissue surrounding the tendon (Fig. 4) and at the tendon-
muscle junction at all time points (Fig. 4). Inside the rup-
tured tendons, Oct 3/4-positive cells could be seen in the
I region at weeks one and two post-rupture (Fig. 5). At
week 17 post-rupture, a few Oct 3/4-positive cells were
observed inside the tendon and they were mainly located
in the vicinity of blood vessel streaks. In control tendons,
no Oct 3/4-positive cells were found in the tendon proper
at any time point (Fig. 5).
Cell density in the ruptured vs. contralateral control
tendon
In the I and MP regions of the ruptured tendons, the cell
density (~2,500-4,000 cells/mm2) was approximately three
times higher compared with the control tendons (~850-
950 cells/mm2) at all time points (I region p < 0.01 weeks
1–8; MP region p < 0.01 weeks 1–8 and p < 0.05 week 17)
(Fig. 6). In the D region, however, the cell density in the
ruptured tendons (1,500-2,000 cells/mm2) was only sig-
nificantly higher at two and eight weeks post-injury as
compared with the controls (~1,200 cells/mm2) (Fig. 6).
Nucleostemin cell density in the ruptured vs. contralateral
control tendon
The density of nucleostemin-positive cells at weeks one
and two post-injury was significantly higher in all re-
gions of ruptured tendons when compared with controltendons. The highest nucleostemin cell density at weeks
one to two was observed in the I and MP regions (~1,500
cells/mm2), while the D region exhibited lower nucleoste-
min cell density (~750 cells/mm2) (Fig. 7).
At weeks one and two post-rupture, the percentage of
nucleostemin-positive cells in the different regions thus
equalled approximately 40 to 60 % of all cells (Fig. 8). At
weeks eight and 17 post-rupture, however, the density of
nucleostemin-positive cells returned to approximately the
same level as in the control tendons (Fig. 8), which equals
around 5-10 % of the total cell number.
Regional differences in nucleostemin-positive cell per-
centage in injured tendons at week 17
Significant differences in the nucleostemin-positive cell
percentage were found when comparing all regions in
injured tendons at 17 weeks post-injury (p < 0.01). The
percentage of nucleostemin-positive cells was specifically
higher in Alcian blue islands compared with the I, MP
and CT regions (p < 0.01 for all), whereas no significant
difference was found when compared with the D region
(Fig. 9).
Discussion
The injured rat Achilles tendon displays structural changes,
with a large increase in cell proliferation throughout the
tendon length. In particular, the three times higher cell
density in the I and MP regions at all observed time points
(up to 17 weeks) suggests a prolonged healing process after
Fig. 5 Dynamin 2 and Oct 3/4 in I region in early tendon healing. Sections showing few positive Oct 3/4 (yellow) (b) and Dyn 2 (green) (f) cells
inside the I region of Achilles rat tendon at one week post-rupture. No Oct 3/4- (d) or Dyn 2- (h) -positive cells were found inside the I region of
control tendons (contralateral intact tendon). Histological staining of sections of ruptured (a,e) and control (c,g) sections was performed on adjacent
consecutive sections. Cell nuclei stained with DAPI (blue)
Fig. 4 Dynamin 2 and Oct 3/4 in CT and MTJ region in rat Achilles tendon. Photomicrographs show the histological staining and adjacent
consecutive sections of Oct 3/4 (yellow) and Dyn 2 (green) staining in ruptured and control tendons from the CT region (a-f) and MTJ region (g-l).
Positive cells for Oct 3/4 and Dyn 2 was seen in both ruptured and control tendons in both regions. All tendon samples are from one or two weeks
post-rupture. Positive control tissue for Oct 3/4 staining was human seminoma tissue (m,n) and rat thymus for Dyn 2 (o,p). Cell nuclei stained with
DAPI (blue)
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A B C
Fig. 6 Cell density in ruptured vs contralateral control tendon. Total cell numbers/mm2 in (a) the distal region, (b) the injury region and (c) the
midproximal region at one, two, eight and 17 weeks post-rupture. A total of six animals were evaluated at each time point. The p values in the
figure represent comparisons between the control (left leg n = 6) and ruptured (right leg n = 6) tendon samples at each time point. Values are
expressed as the median with IQR as error bars
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mechanical transmission of force. Moreover, the numbers
of stem/progenitor cells not only increase in the injured
region but are also identified as upregulated numbers
throughout the tendon length, implying a non-specificA B
Fig. 7 Nucleostemin cell density in ruptured vs contralateral control tend
midproximal (c) regions at one, two, eight and 17 weeks post-rupture. A
in the figure represent comparisons between the control (left leg n = 6) a
expressed as the median with IQR as error barsgeneral role in the healing process. Most of these stem/
progenitor cells at this time point (1 and 2 weeks post-
injury) were found to have a nucleostemin-positive pheno-
type. Nucleostemin is expressed predominantly in primi-
tive undifferentiated cells and has been used as a stem/C
on. Nucleostemin-positive cells/mm2 in the distal (a), injury (b) and
total of six animals were evaluated at each time point. The p values
nd ruptured (right leg n = 6) tendon at each time point. Values are
Fig. 8 Nucleostemin percentage and presence in response to tendon rupture. Images showing immunofluorescence staining of the stem cell
marker, nucleostemin (red), in control (a-c) and ruptured (d-f) rat Achilles tendon at week two post-rupture. Diagrams showing the percentage of
nucleostemin-positive cells in the distal (g), injury (h) and midproximal (i) regions at one, two, eight and 17 weeks post-rupture. A total of six animals
were evaluated at each time point. The p values in the figure represent comparisons between the control (left leg n = 6) and ruptured (right leg n = 6)
tendon at each time point. Values are expressed as the median with IQR as error bars
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ies have shown that nucleostemin is involved in prolifera-
tion processes, either in stem/progenitor cells or in cancer
cells [17, 18]. In the context of the ruptured Achilles ten-
don, nucleostemin-positive cells increase, with an incre-
ment of up to 40-60 % of the total cell number in the
early healing phase, suggesting that they play an important
role in the cell proliferation of a healing rat tendon. A
similar finding has been reported in mouse myocardium,where the induction of nucleostemin was seen in cardio-
myocytes following cardiomyopathic injury [15]. Further-
more, the forced overexpression of nucleostemin in
cultured cardiac stem cells significantly increased their cell
proliferation and the authors proposed the potential use
of nucleostemin as a molecular interventional tool in car-
diac pathophysiological conditions [15]. Nucleostemin
could possibly also be used in interventional strategies for
tendon regeneration.
Fig. 9 Nucleostemin percentage and presence at different locations in healing tendon at week 17. The percentage of nucleostemin-positive cells
was calculated in five different regions from ruptured (right leg; n = 6) tendons at week 17. The diagram (a) shows a significantly higher percent-
age of nucleostemin-positive cells in regions with high Alcian blue content (AB islands) compared with I, MP and CT regions. Values are expressed
as the median with IQR as error bars. Images showing histological staining (b-f) and nucleostemin (red) staining (h-l) in the different regions of
the tendons. Positive control tissue for nucleostemin was human seminoma tissue (g,m)
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within the injured tendons, mainly in the I region, sug-
gests a more precise role for these cells in this area of the
healing rat tendon. The source of these stem/progenitor
cells may be the tissues surrounding the tendon, as more
Oct 3/4-positive cells were identified in the loose connect-
ive tissue surrounding the tendon (peritendon) and in the
MTJ region in both control and ruptured tendons. Our
observation of Oct 3/4 in the same location as Dynamin 2,
a large GTPase recently found to stimulate tenocyte mi-
gration [19], furthermore indicates the migration potential
of these cells, which was not seen with the nucleostemin-
positive cells. Several reports indicate that the stem/pro-
genitor cell populations in and around the tendon are
mixed [8, 9, 11] and this probably also applies to the Oct
3/4-positive and nucleostemin-positive cell population in
this study, as none of these markers specifically detect
only a single homogeny variant of stem/progenitor cells. It
is well established that tendon healing occurs through
both intrinsic and extrinsic healing [20] and Cadby et al.
found that the peritenon stem/progenitor cells appeared
to have a faster migration rate and a higher expression of
mesenchymal stem cell (MSC) markers [8]. Furthermore,
Mienaltowski et al. [12] provided evidence that peritendonprogenitors secrete a factor/factors which stimulates/
stimulate tenogenic differentiation in tendon-proper pro-
genitors and tenocytes, suggesting a trophic role for the
peritendon progenitors.
Whether the Oct 3/4-positive cells found inside the in-
jury region, in contrast to the nucleostemin-positive cells,
are peritendon-derived MSCs needs be further evaluated,
but the migration of endogenous stem/progenitor cells in
tendon repair tissue has recently been shown in rat patel-
lar tendon [11]. The MSCs have the potential to act as
both immunosuppressors and regulators of proliferation
and extracellular matrix production in damaged tissue
[21]. The Oct 3/4-positive stem/progenitor cells observed
inside the I region may thus perform a wider regulatory
role, such as the orchestration of both inflammatory and
proliferative processes during tendon repair. Nucleostemin-
positive stem/progenitor cells, on the other hand, may have
a general mission to increase the cell population by activat-
ing cell proliferation.
Moreover, it was shown that the D region had a
smaller increase in both nucleostemin-positive cells and
overall cell density at the early time points post-tendon
rupture when compared with the I and MP regions.
This was surprising, as, in a previous study, it was
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higher resident pool of stem/progenitor cells compared
with the MP region [10]. This was subsequently con-
firmed in a study of rat patellar tendon by Tan et al.
[11]. By 17 weeks post-rupture, we found that the total
cell density in the D region of ruptured tendons had
returned to normal levels, unlike the I and MP regions,
which still had significantly higher cell densities compared
with the control tendons. Whether the larger pool of
resident (intrinsic) stem/progenitor cells in the D region
in rat Achilles tendon causes this region to require less
external (extrinsic) assistance in healing processes after a
mid-rupture needs to be studied in more detail. It should
be noted that the number of nucleostemin-positive cells
in the D region in the present study did not differ from
the numbers found in the I and MP regions of control
tendons in our previous report [10]. However, in the
present study, the contralateral left tendon was used as a
control and the possibility that some bilateral neuronal
effect affected the contralateral tendon, as seen in both rat
and rabbit tendon, cannot be excluded [22, 23].
When the tendon healing had entered the remodel-
ling phase (8–17 weeks post-rupture), the number of
nucleostemin-positive cells declined to a level compar-
able to the levels in control tendons, an indication that
the cells had lost their stem/progenitor phenotype and
entered into a more differentiated state in which prolif-
eration had diminished. The constant high levels of
total cells found in the I and MP regions of the tendon
compared with the D region at these time points indicate
that the remodelling phase in these areas has a hetero-
genic healing pattern and may reflect less demand in the
D region for remodelling processes such as increased
collagen I production [1, 24]. At these time points, we fur-
thermore found residing islands of high proteoglycan con-
tent (Alcian blue staining), mainly situated in the I and
MP regions. They contained cells that were histologically
more consistent with a chondrogenic profile and may
therefore create a potential disturbance in rebuilding the
tendon-proper matrix, leading to biomechanically inferior
tissue. Significantly higher proportions of nucleostemin-
positive cells were found in these regions when compared
with regions with no visible Alcian blue staining, indicat-
ing a higher proliferation state and a possible regeneration
error in these areas. Interestingly, a recent report by Asai
et al. [25] found that progenitor cells from injured tendons
had greater chondrogenic potential than progenitors
from uninjured tendons and may therefore contribute
to chondrogenic degeneration in tendon healing. When
transplanted into an injured tendon, a subpopulation of
progenitor cells with a CD105-negative phenotype was
found to be more likely to induce chondrogenic degener-
ation at the edges of the injured region compared with
progenitors at the centre of the injury. The authorssuggested that differences in mechanical forces in these
regions may explain the regulation when obtaining
tendon-proper tissue regeneration or chondrogenic tissue
degeneration. Whether different mechanical influences
are responsible for the histological differences in the
Alcian blue islands seen in the present study remains to
be clarified, but this could provide valuable information
when it comes to acquiring a better insight into ways of
retaining a tendon with more optimal mechanical function
after a rupture.
This study is not without its limitations. First, we did
not study each day during the first week after an Achilles
tendon rupture and no data on exactly when stem/pro-
genitor cells emerge in the tendon rupture together with
the first inflammatory response are therefore available.
Second, the transcription factor, Oct4, is able to encode
two functional isoforms, Oct4A and Oct4B, whereas only
the Oct4A isoform is able to sustain stem cell properties
[26]. In addition, there are several homologous pseudo-
genes which may give false-positive results [27]. For this
reason, we used the monoclonal antibody, sc-5279 (Santa
Cruz), which specifically recognises the Oct4A isoform,
excluding any false interpretation of Oct4B staining [27].
Conclusions
In conclusion, a substantial cell increase, combined
with a high proportion of stem/progenitor cells, was
seen throughout the length of the Achilles tendon after
a mid-tendon rupture. The large number of stem/pro-
genitor cells with nucleostemin expression could be of
general importance in proliferation maintenance in all
tendon regions, while the few stem/progenitor cells
with Oct 3/4 expression, mainly seen inside the I re-
gion, may perform a more specific regulatory role in
the healing tendon. Moreover, the distal tendon region
appears to require less extrinsic healing assistance. Res-
iding proteoglycan-rich areas containing clusters of
more chondrocyte-like cells, in combination with higher
proportions of nucleostemin-positive cells, may be an in-
dication of a specific co-ordination problem in the healing
processes, which might have a negative impact on the
mechanical function after an Achilles mid-tendon rupture.
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